Technische Universität München
Stories about Resonance
- more
New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
moreTerumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
moreFraunhofer Institut für Angewandte Festkörperphysik IAF
PCB-embedded GaN-on-Si half bridge circuits for modular use
moreTechnische Universität München
TUM spin-offs take all three podium positions
moreTechnische Universität München
Artificial neural network resolves puzzles from condensed matter physics
moreFraunhofer Institut für Angewandte Festkörperphysik IAF
Fingerprint spectroscopy within a millisecond
moreTechnische Universität München
How molecular escorts help prevent cancer: Chaperones keep the tumor suppressor protein p53 in check
moreSpecific identification of chronic lung disease in premature babies
moreTechnische Universität München
ERC Grants awarded to TUM researchers
moreFraunhofer Institut für Angewandte Festkörperphysik IAF
Quantum Magnetometers for Industrial Applications
moreFDA Approves MAVENCLAD® (Cladribine) Tablets as First and Only Short-Course Oral Treatment for Relapsing-Remitting and Active Secondary Progressive Multiple Sclerosis
moreMAVENCLAD® (Cladribine Tablets) Approved As The First Short-Course Oral Treatment for Relapsing Remitting Multiple Sclerosis in Switzerland
moreSiemens Financial Services GmbH
Siemens Financial Services invests in Greenko Group's 200 MW Poovani Wind Power Project
moreFraunhofer Institut für Angewandte Festkörperphysik IAF
Press release: A breakthrough in cardiac metabolic MR imaging
moreFraunhofer Institut für Angewandte Festkörperphysik IAF
Measuring Smallest Magnetic Fields in the Brain Using Diamond and Laser Technology // Quantum sensors - Fraunhofer IAF launches a project for medical applications
more
1